IGLON5 and movement disorder: In this French cohort, by the time of diagnosis, all patients had a multidomain clinical presentation, a similar figure than in the ICS development cohorts [12], with a predominance of bulbar, sleep, and movement disorders, which is consistent with the classical clinical profile of anti-IgLON5 disease [2, 8, 10, 11].